SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 2,400.85 |
| Enterprise Value ($M) | 2,357.44 |
| Book Value ($M) | 536.77 |
| Book Value / Share | 7.94 |
| Price / Book | 4.47 |
| NCAV ($M) | 536.38 |
| NCAV / Share | 7.93 |
| Price / NCAV | 4.48 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.14 |
| Return on Assets (ROA) | -0.34 |
| Return on Equity (ROE) | -0.36 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 35.32 |
| Current Ratio | 35.32 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 552.08 |
| Assets | 552.47 |
| Liabilities | 15.70 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Vanguard Group Inc | 7.57 | 0.00 | |
| 13G | BlackRock, Inc. | 5.30 | 0.00 | |
| 13G | Unique Diamond Investments Ltd | 8.30 | ||
| 13G/A | Decheng Capital Global Life Sciences Fund IV, L.P. | 8.20 | 7.91 | |
| 13G | Kissei Pharmaceutical Co., Ltd. | 5.30 | ||
| 13G | TCG Crossover GP I, LLC | 5.40 | ||
| 13G | Longitude Capital Partners IV, LLC | 7.00 | ||
| 13G | Foresite Capital Fund V, L.P. | 5.70 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION WASHINGTON, DC 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 229,996 | 663,676 | 34.65 | |
| 128,431 | 597,766 | 21.49 | |
| 85,773 | 350,966 | 24.44 | |
| 86,735 | 428,440 | 20.24 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| CCCC – C4 Therapeutics, Inc. | CGC – Canopy Growth Corporation |
| CGEM – Cullinan Therapeutics, Inc. | COGT – Cogent Biosciences, Inc. |
| COLL – Collegium Pharmaceutical, Inc. |
Financial data and stock pages provided by
Fintel.io